Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency
Carnitine palmitoyltransferase 1A (CPT1A) deficiency is an inherited disorder of mitochondrial fatty acid β-oxidation that impairs fasting ketogenesis and gluconeogenesis in the liver. Few studies implementing newborn screening (NBS) for CPT1A deficiency in the Chinese population have been reported....
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7e9a8c9eb4cd465694b4ffde276aaf06 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7e9a8c9eb4cd465694b4ffde276aaf06 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7e9a8c9eb4cd465694b4ffde276aaf062021-11-12T06:43:33ZThree Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency2296-236010.3389/fped.2021.771922https://doaj.org/article/7e9a8c9eb4cd465694b4ffde276aaf062021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fped.2021.771922/fullhttps://doaj.org/toc/2296-2360Carnitine palmitoyltransferase 1A (CPT1A) deficiency is an inherited disorder of mitochondrial fatty acid β-oxidation that impairs fasting ketogenesis and gluconeogenesis in the liver. Few studies implementing newborn screening (NBS) for CPT1A deficiency in the Chinese population have been reported. This study aimed to determine the biochemical, clinical, and genetic characteristics of patients with CPT1A deficiency in China. A total of 204,777 newborns were screened using tandem mass spectrometry at Quanzhou Maternity and Children's Hospital between January 2017 and December 2018. Newborns with elevated C0 levels were recruited, and suspected patients were subjected to further genetic analysis. Additionally, all Chinese patients genetically diagnosed with CPT1A deficiency were reviewed and included in the study. Among the 204,777 screened newborns, two patients were diagnosed with CPT1A deficiency; thus, the estimated incidence in the selected population was 1:102,388. In addition to the two patients newly diagnosed with CPT1A deficiency, we included in our cohort 10 Chinese patients who were previously diagnosed. Five of these 12 patients were diagnosed via NBS. All patients exhibited elevated C0 and/or C0/(C16+C18) ratios. No clinical symptoms were observed in the five patients diagnosed via NBS, while all seven patients presented with clinical symptoms, including fever, cough, vomiting, diarrhea, and seizures. Eighteen distinct CPT1A variants were identified, 15 of which have been previously reported. The three novel variants were c.272T>C (p.L91P), c.734G>A (p.R245Q), and c.1336G>A (p.G446S). in silico analysis suggested that all three novel variants were potentially pathogenic. The most common variant was c.2201T>C (p.F734S), with an allelic frequency of 16.67% (4/24). Our findings demonstrated that NBS for CPT1A deficiency is beneficial. The three novel variants expand the mutational spectrum of CPT1A in the Chinese population, and c.2201T>C (p.F734S) may be a potential hotspot CPT1A mutation.Weifeng ZhangYanru ChenChunmei LinWeilin PengQingliu FuYiming LinFrontiers Media S.A.articlenewborn screeningcarnitine palmitoyltransferase 1A deficiencyin silico predictionCPT1A genetandem mass spectrometryPediatricsRJ1-570ENFrontiers in Pediatrics, Vol 9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
newborn screening carnitine palmitoyltransferase 1A deficiency in silico prediction CPT1A gene tandem mass spectrometry Pediatrics RJ1-570 |
| spellingShingle |
newborn screening carnitine palmitoyltransferase 1A deficiency in silico prediction CPT1A gene tandem mass spectrometry Pediatrics RJ1-570 Weifeng Zhang Yanru Chen Chunmei Lin Weilin Peng Qingliu Fu Yiming Lin Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| description |
Carnitine palmitoyltransferase 1A (CPT1A) deficiency is an inherited disorder of mitochondrial fatty acid β-oxidation that impairs fasting ketogenesis and gluconeogenesis in the liver. Few studies implementing newborn screening (NBS) for CPT1A deficiency in the Chinese population have been reported. This study aimed to determine the biochemical, clinical, and genetic characteristics of patients with CPT1A deficiency in China. A total of 204,777 newborns were screened using tandem mass spectrometry at Quanzhou Maternity and Children's Hospital between January 2017 and December 2018. Newborns with elevated C0 levels were recruited, and suspected patients were subjected to further genetic analysis. Additionally, all Chinese patients genetically diagnosed with CPT1A deficiency were reviewed and included in the study. Among the 204,777 screened newborns, two patients were diagnosed with CPT1A deficiency; thus, the estimated incidence in the selected population was 1:102,388. In addition to the two patients newly diagnosed with CPT1A deficiency, we included in our cohort 10 Chinese patients who were previously diagnosed. Five of these 12 patients were diagnosed via NBS. All patients exhibited elevated C0 and/or C0/(C16+C18) ratios. No clinical symptoms were observed in the five patients diagnosed via NBS, while all seven patients presented with clinical symptoms, including fever, cough, vomiting, diarrhea, and seizures. Eighteen distinct CPT1A variants were identified, 15 of which have been previously reported. The three novel variants were c.272T>C (p.L91P), c.734G>A (p.R245Q), and c.1336G>A (p.G446S). in silico analysis suggested that all three novel variants were potentially pathogenic. The most common variant was c.2201T>C (p.F734S), with an allelic frequency of 16.67% (4/24). Our findings demonstrated that NBS for CPT1A deficiency is beneficial. The three novel variants expand the mutational spectrum of CPT1A in the Chinese population, and c.2201T>C (p.F734S) may be a potential hotspot CPT1A mutation. |
| format |
article |
| author |
Weifeng Zhang Yanru Chen Chunmei Lin Weilin Peng Qingliu Fu Yiming Lin |
| author_facet |
Weifeng Zhang Yanru Chen Chunmei Lin Weilin Peng Qingliu Fu Yiming Lin |
| author_sort |
Weifeng Zhang |
| title |
Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| title_short |
Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| title_full |
Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| title_fullStr |
Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| title_full_unstemmed |
Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency |
| title_sort |
three novel and one potential hotspot cpt1a variants in chinese patients with carnitine palmitoyltransferase 1a deficiency |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/7e9a8c9eb4cd465694b4ffde276aaf06 |
| work_keys_str_mv |
AT weifengzhang threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency AT yanruchen threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency AT chunmeilin threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency AT weilinpeng threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency AT qingliufu threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency AT yiminglin threenovelandonepotentialhotspotcpt1avariantsinchinesepatientswithcarnitinepalmitoyltransferase1adeficiency |
| _version_ |
1718431117552386048 |